Detalhe da pesquisa
1.
Antitumor activity of pegylated human interferon ß as monotherapy or in combination with immune checkpoint inhibitors via tumor growth inhibition and dendritic cell activation.
Cell Immunol
; 393-394: 104782, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931572